APA (7th ed.) Citation

Shi, Y., McKenery, A., Dolan, M., Mastri, M., Hill, J. W., Dommer, A., . . . Ebos, J. M. L. (2025). Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors. EMBO reports, 26(2), 521-559. https://doi.org/10.1038/s44319-024-00333-0

Chicago Style (17th ed.) Citation

Shi, Yuhao, et al. "Acquired Resistance to PD-L1 Inhibition Enhances a Type I IFN-regulated Secretory Program in Tumors." EMBO Reports 26, no. 2 (2025): 521-559. https://doi.org/10.1038/s44319-024-00333-0.

MLA (9th ed.) Citation

Shi, Yuhao, et al. "Acquired Resistance to PD-L1 Inhibition Enhances a Type I IFN-regulated Secretory Program in Tumors." EMBO Reports, vol. 26, no. 2, 2025, pp. 521-559, https://doi.org/10.1038/s44319-024-00333-0.